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ABSTRACT 
Prenatal maternal stress exposure has been associated with neonatal differential DNA 
methylation. However, the available evidence in humans is largely based on candidate gene 
methylation studies, where only a few CpG sites were evaluated. The aim of this study was to 
examine the association between prenatal exposure to maternal stress and offspring genome-
wide cord blood methylation using different methods. First, we conducted a meta-analysis and 
follow-up pathway analyses. Second, we used novel region discovery methods [i.e., differentially 
methylated regions (DMRs) analyses]. To this end, we used data from two independent 
population-based studies, the Generation R Study (n = 912) and the Avon Longitudinal Study of 
Parents and Children (ALSPAC, n = 828), to (i) measure genome-wide DNA methylation in cord 
blood; and (ii) extract a prenatal maternal stress composite. The meta-analysis (ntotal = 1,740) 
revealed no epigenome-wide (meta p < 1.00e-07) associations of prenatal maternal stress 
exposure with neonatal differential DNA methylation. Follow-up analyses of the top hits derived 
from our epigenome-wide meta-analysis (meta p < 1.00e-04) indicated an over-representation of 
the methyltransferase activity pathway. We identified no Bonferroni-corrected (p < 1.00e-06) 
DMRs associated with prenatal maternal stress exposure. Combining data from two independent 
population-based samples in an epigenome-wide meta-analysis, the current study indicates that 
there are no large effects of prenatal maternal stress exposure on neonatal DNA methylation. 
Key words: prenatal maternal stress; DNA methylation; cord blood; epigenome-wide 
association study (EWAS); birth cohort  
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Introduction 
Exposure to maternal stress in utero can negatively affect development in later life. 1-4 
For example, prenatal exposure to maternal depressive symptoms5 and contextual stress (e.g., 
economic disadvantage)6 have been associated with increased risk for offspring problem 
behavior, beyond variance attributable to postnatal exposures. It is increasingly recognized that 
epigenetic mechanisms, such as DNA methylation, might help explain the link between prenatal 
exposure to maternal stress and adverse developmental consequences. 7, 8 The extent to which 
prenatal maternal stress exposure relates to offspring genome-wide DNA methylation at birth 
remains unclear. 
The vast majority of studies investigating the association between prenatal exposure to 
maternal stress and offspring methylation at birth have focused on candidate genes. 9-14 For 
example, Cecil et al.9 demonstrated that neonates who were exposed to maternal stress (e.g., 
maternal psychopathology, criminal behaviors, substance use) in the prenatal period had higher 
methylation levels of the oxytocin receptor (OXTR) gene than non-exposed neonates. Higher 
neonatal OXTR methylation, in turn, showed temporal stability (from birth to 9 years of age) and 
was associated with callous-unemotional traits at age 13 years independent of postnatal stress 
exposure and associated OXTR methylation. 9 Similarly, prenatal exposure to maternal 
depressive symptoms has been associated with altered methylation of the serotonergic SLC6A4 
gene, 10 the glucocorticoid receptor (NR3C1) gene, 11 and imprinted genes12-14 in neonates or 
infants. Overall, the findings of these candidate gene studies support the “fetal programming 
hypothesis”, 15 suggesting that exposure of the fetus to maternal stress in utero may influence 
DNA methylation in genes involved in fundamental developmental processes.  
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Since strong prior biological knowledge of the complex association between prenatal 
maternal stress exposure and offspring differential DNA methylation is lacking, it is critical to 
perform hypothesis-free, epigenome-wide association studies (EWASs) in addition to candidate 
gene studies. 16, 17 The few EWASs that have investigated the association between prenatal 
maternal stress exposure and offspring DNA methylation suffer from small sample sizes with 
limited generalizability and they have produced conflicting findings. 18 Non et al.19 reported an 
association between prenatal exposure to maternal depression and offspring DNA methylation in 
36 mother-offspring pairs. However, using a larger but still modest sample of 201 neonates born 
to mothers receiving psychiatric care, Schroeder et al.20 reported that maternal depression during 
pregnancy was unrelated to neonatal DNA methylation. Another small EWAS (n = 36) provided 
evidence that prenatal exposure to a natural disaster (i.e., the Quebec ice storm in 1998) was 
associated with offspring methylation in multiple genes predominantly related to immune 
function. 21 However, DNA methylation was measured eight to 13 years after exposure and it 
cannot be excluded that the observed DNA methylation patterns were associated with 
unmeasured long-lasting environmental factors that were related to the original natural disaster 
but occurred after the prenatal period. As such, EWASs must be conducted in large samples of 
neonates and their mothers before more definite conclusions can be reached.  
The aim of this study was to examine the association between prenatal exposure to 
maternal stress and offspring genome-wide cord blood methylation using different methods. 
First, we conducted a meta-analysis and follow-up pathway analyses. Second, we used novel 
region discovery methods [i.e., differentially methylated regions (DMRs) analyses] that are 
tailored to the Illumina Infinium HumanMethylation450K BeadChip array22 but are not designed 
for meta-analysis. To this end, we used data from two independent population-based studies, the 
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Generation R Study (n = 912) and the Avon Longitudinal Study of Parents and Children 
(ALSPAC, n = 828), to (i) measure genome-wide DNA methylation at birth (via cord blood), 
when it is not confounded by the effects of stressful postnatal conditions; and (ii) extract a 
prenatal maternal stress composite. The fact that ALSPAC and Generation R are highly 
compatible enabled us to study 450K HumanMethylation neonatal methylation in similar 
populations and use a similar phenotype definition. Of note, although the 450K 
HumanMethylation array is considered a highly suitable platform for large-scale studies, it 
targets only < 2% of the CpG sites present in the human genome. 17 The current study is one of 
the largest in this emerging field of EWAS, and the built-in meta-analysis and follow-up 
analyses might serve as a model for future studies. 
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Methods 
Study Design and Participants  
This study used data from two population-based cohorts, the Generation R Study and the 
Avon Longitudinal Study of Parents and Children (ALSPAC). Generation R is an ongoing 
epidemiological study of children born from 9,778 pregnant women residing in Rotterdam, the 
Netherlands, with expected delivery dates between April 2002 and January 2006. The design and 
sample characteristics of the Generation R Study have been described in detail elsewhere. 23, 24 
The study was conducted in accordance with the guidelines proposed in the World Medical 
Association Declaration of Helsinki and was approved by the Medical Ethical Committee of the 
Erasmus University Medical Center, Rotterdam. The current research used a subsample of 969 
Caucasian Dutch neonates and their mothers drawn from the Generation R Focus Study, an 
ethnically homogeneous subsample nested within the Generation R cohort, who had epigenetic 
data at birth that successfully passed quality control.  
ALSPAC is an ongoing epidemiological study of children born from 14,541 pregnant 
women residing in Avon, UK, with an expected delivery date between April 1991 and December 
1992 (85% of eligible population). 25 The sample is representative of the general population. 26 
More details of the available data are available in the study website through a fully searchable 
data dictionary (http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/). Ethical 
approval was obtained from the ALSPAC Law and Ethics Committee as well as Local Research 
Committees. The current research used a subsample of 914 mother-offspring pairs drawn from 
the Accessible Resource for Integrated Epigenomics Studies (ARIES27, 
www.ariesepigenomics.org.uk) nested within ALSPAC, who had cord blood methylation data 
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available that successfully passed initial quality control, before carrying out additional quality 
steps (see below). 
Except for the factor analysis on prenatal adversities, in which we used data from all 
participants, the present study only included participants who had complete data for prenatal 
maternal stress exposure and methylation data (Generation R: n = 912; ALSPAC: n = 828). In 
both studies parents signed written consent for participation. 
Measures 
DNA methylation data 
In Generation R and ALSPAC, 500 nanograms of DNA from cord-blood (birth, nGeneration 
R = 979; nALSPAC = 914) underwent bisulfite conversion using the EZ-96 DNA Methylation Kit 
(Zymo Research Corporation, Irvine, USA). The Illumina Infinium HumanMethylation450 
BeadChip Kit (Illumina Inc., San Diego, USA) was used to measure DNA methylation at 
485,577 CpG probes. In both datasets, initial quality control of data generated was conducted to 
determine the status of staining, extension, hybridization, target removal, bisulfite conversion, 
specificity, non-polymorphic and negative controls. 
The Generation R sample included the 969 neonates who had DNA methylation data that 
passed quality control. All 49,564 probes identified as having (i) a single nucleotide 
polymorphism in the single base extension site with a frequency of > 1% in the GoNLv4 
reference panel28 or (ii) a non-optimal binding (non-mapping or mapping multiple times to either 
the normal or the bisulfite-converted genome) were removed from the dataset, leaving a total of 
436,013 CpG probes for analysis. 
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In ALSPAC, DNA methylation data was only available in samples that passed initial 
control. Furthermore, samples (n = 25) or probes (n = 7,873) that failed additional quality control 
steps (>1% probes/ samples with background detection p-value >= .05) were excluded from 
further analyses. In ALSPAC, participants with non-Caucasian or missing ethnicity (based on 
self-reports, n = 61) were removed prior to the analysis. This left a total of 828 samples and 
477,704 probes after quality control.  
Both samples were normalized using the dasen method described by Pidsley et al.29and 
dye bias corrected. 30 Normalized values are beta-values, which represent the methylation level 
at a CpG probe for each neonate. Last, only probes (n = 429,074) that were present in both 
Generation R and ALSPAC datasets (i.e., probes that passed quality control in both datasets) 
were included in all analyses. 
Prenatal Maternal Stress Exposure 
A prenatal maternal stress exposure (PMSE) score had been previously created in 
ALSPAC based on maternal reports, covering four stress domains: (i) life stress (e.g., death in 
family, illness, work problems), (ii) contextual stress (e.g., financial difficulties, housing 
problems), (iii) personal stress (e.g., psychopathology, substance abuse including alcohol and 
drugs), and (iv) interpersonal stress (e.g., family relationship difficulties, arguments with 
partner). 9 ALSPAC and Generation R have highly compatible measures enabling us to create a 
similar PMSE score in Generation R, based on maternal reports. For each domain, items were 
summed and divided by the number of completed items. Inter-correlations between the risk 
domain scores were positive (all p < .001). Confirmatory factor analysis (CFA) in Mplus 7.1131 
was used to assess the internal reliability of the stress domains and to extract one PMSE score in 
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the whole Generation R cohort, showing good model fit (RMSEA; acceptable fit ≤ 0.08; CFI and 
TLI; acceptable fit ≥ 0.90). 32, 33 See Supplementary Material for full item descriptions (Table 
S1), inter-correlations between the stress domains (Table S2), and the confirmatory factor 
analysis model and fit indices (Figure S1). 
In both studies, the PMSE score was logarithmic (base 10) transformed to approximate a 
normal distribution. Additionally, the transformed PMSE score was translated into z scores and 
screened for outliers (values were Winsorized when z-score ≥ 3.29, affecting n = 8 
measurements in Generation R and n = 5 in ALSPAC). These analyses were conducted in SPSS 
21.0 statistical package. 34  
Covariates  
We adjusted for technical covariates, including the sample’s array number and position 
on the array. Following the methods developed by Houseman et al.35, we included estimated 
proportions of cells in whole blood [proportion of CD8+ T-cells, CD4+ T-cells, natural killer 
(NK) cells, B-cells, monocytes and granulocytes] to adjust for different cell type compositions. 
Because the cell type proportions add up to approximately 100%, granulocytes were excluded to 
avoid multicollinearity. 
Furthermore, we included as covariates child sex, gestational age at birth, and maternal 
smoking during pregnancy. In Generation R, information on child sex was obtained from 
midwife and hospital registries at birth. Gestational age at birth was established by fetal 
ultrasound examination. Information on maternal tobacco smoking was obtained by postal 
questionnaires in early, mid-, and late pregnancy. Maternal smoking was categorized on the basis 
of all three questionnaires into “never smoked during pregnancy”, “quit as soon as pregnancy 
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was known”, and “continued smoking during pregnancy”. In ALSPAC, information on child sex 
and gestational age at birth was obtained from self-reports, health and administrative records. 
Information on maternal tobacco smoking was obtained by self-reported questionnaires in early, 
mid-, and late pregnancy.  
Statistical Analysis 
Epigenome-Wide Association Study (EWAS) and Meta-Analysis 
First, single probe analyses investigating the association between the PMSE score and 
neonatal DNA methylation were performed for the CpG probes (n = 429,074) that passed quality 
control in both the Generation R and ALSPAC cohorts. We used a linear mixed effects model, 
adjusting for fixed (i.e., gestational age, sex, maternal smoking during pregnancy, cell types 
estimation) and random (i.e., the sample’s array number and position on the array) covariates.  
Second, to maximize power to detect an association of the PMSE score with DNA 
methylation in neonates, we combined the data from the two independent samples in an EWAS 
meta-analysis. In this study, we performed both fixed- and random-effects, inverse-variance 
meta-analysis using the methods implemented in METAL (Meta-Analysis Helper)36, and 
METASOFT37, respectively. We also investigated evidence of heterogeneity in the Generation R 
and ALSPAC data using the I2- statistic38, considering only results with no strong evidence of 
heterogeneity (Heterogeneity p > .05) for further analysis. Of note, the power to detect 
heterogeneity is limited with small numbers of studies. Bonferroni (p = 1.00e-07) and FDR 
corrections were applied as epigenome-wide thresholds. 
We conducted a sensitivity EWAS of extreme groups in Generation R to test the 
possibility that only extreme prenatal maternal stress would lead to differential methylation. 
11 
 
Specifically, we dichotomized PMSE according to the 10% highest (n = 91) and the 10% lowest 
(n = 82) scores and used this binary variable in a discovery EWAS. 
Correlation Test  
A correlation test was used to investigate the linear relationship of the effect sizes of CpG 
probes between the Generation R and ALSPAC samples. To this end, all CpG probes showing an 
association at a nominal threshold level (meta p < .05) in our EWAS meta-analysis were selected 
and the Pearson correlation of the effect sizes between the Generation R and ALSPAC samples 
was estimated. We also considered the sign of the regression coefficients. 
Epigenome-Wide Pathway Analyses 
To investigate whether specific pathways are over-represented in our EWAS meta-
analysis results, epigenome-wide pathway analyses were performed. For this purpose, all top hits 
derived from the EWAS meta-analysis (meta p < 1.00e-04) were selected and annotated to genes, 
using the IlluminaHumanMethylation450kCHR36 file. We used 3 different tools to sort these 
genes into pathways: (i) the PANTHER 9.0 pathway-classification tool39, using the Gene 
Ontology (GO)-Slim Molecular Function annotation dataset40, (ii) DAVID (Database for 
Annotation, Visualization, and Integrated Discovery)41, and (iii) GeneMANIA42, based on GO 
terms. These methods adjust for differential gene size but not the unusual distribution of 450K 
HumanMethylation probes with respect to the gene. It is recommended to use multiple tools 
when conducting pathway analysis, to overcome methodological challenges specific to each tool. 
43 
Differentially Methylated Regions (DMRs) analysis  
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Differentially Methylated Regions (DMRs) are defined as at least two spatially 
contiguous probes within 1kb distance of each other and with a differential statistic consistently 
less than the 5th (for negative associations) or more than the 95th percentile (for positive 
associations). 44 To identify DMRs associated with PMSE in neonates, we first used the 
clusterMaker function of the bumphunter package45 to assign CpG probes into clusters, separated 
with a maximum distance of 1kb within the Generation R sample. For each cluster, we used the 
GlobalTest statistical package46 to test the association between prenatal stress and differential 
methylation of each of these clusters, using a linear regression model, while adjusting for 
covariates. Finally, the top clusters identified in the Generation R sample were tested for 
association with PMSE in the ALSPAC sample, using the same linear regression model in the 
GlobalTest statistical package.  
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Results 
Sample Characteristics 
The sample characteristics for all mothers and children participating in this study are 
presented in Table 1. The distribution of mean cord blood methylation values (β-values) in 
Generation R (n = 912) and ALSPAC (n = 828) is presented in Table 2. 
Epigenome-wide Association Analysis Meta-analysis 
Both the individual study epigenome-wide analyses and the meta-analysis (ntotal = 1,740) 
revealed no epigenome-wide (Bonferroni- or FDR-corrected p-value) association of the PMSE 
score with neonatal DNA methylation. The top 10 CpG probes derived from the fixed-effects 
EWAS meta-analysis are presented in Table 3. More detailed tables with all top CpG probes (p 
< 1.00e-04) derived from the EWAS in the Generation R and ALSPAC samples, as well as the 
EWAS meta-analysis in the total sample, can be found in the Supplementary Material (Tables 
S3-S5, respectively). The Manhattan and quantile-quantile plot of the EWAS meta-analysis are 
presented in Figures 1 and 2, respectively. The random-effects EWAS meta-analysis revealed 
similar results as the fixed-effects EWAS meta-analysis. All top CpG probes identified by the 
random-effects EWAS meta-analysis are presented in the Supplementary Material (Table S6). 
Finally, the nCpGs = 39,308 probes with weak evidence of differential methylation in the EWAS 
meta-analysis (meta p < .05) showed a strong correlation across the two samples [r(39,308) = 
.75, p < .01]. Of these 39,308 CpG correlations, 38,000 (97%) went in the same direction across 
Generation R and ALSPAC. 
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 The sensitivity EWAS of extreme groups (i.e., 10% highest versus 10% lowest PMSE 
scores) in Generation R similarly revealed no epigenome-wide association of PMSE with 
neonatal DNA methylation (data available upon request). 
Epigenome-Wide Pathway Analysis 
Three different pathway analyses tools (i.e., PANTHER, DAVID, and GeneMANIA) 
were used to test for over-representation of specific pathways within the top CpG probes (meta p 
< 1.00e-04) identified by our EWAS meta-analysis. The methyltransferase activity pathway was 
enriched in both PANTHER (Bonferroni-corrected p = .002) and GeneMANIA (false discovery 
rate, FDR p = 4.76e-04), and marginally enriched in DAVID (FDR p = .06) after correction for 
the number of pathways tested. Note that the same genes can participate in different pathways, 
making them not completely independent. The output of the pathway analysis tools is presented 
in Table 4.  
Differentially Methylated Regions (DMRs) Analysis 
In Generation R, ntotal = 151,704 clusters were identified, of which n>2 = 49,091 clusters 
contained more than 2 probes. These 49,091 clusters were tested for an association with the 
PMSE score. This analysis identified no Bonferroni-corrected (p = 0.05/49,091 = 1.00e-06) 
DMRS associated with prenatal maternal stress exposure in the Generation R sample. However, 
three DMRs, located in 20q13.33, 7q33, and 17q25.1, showed marginal associations with 
prenatal maternal stress. These three top DMRs were taken forward for replication in the 
ALSPAC sample. None of these regions were associated with PMSE in the ALSPAC sample. 
The results of the DMR analysis are presented in Table 5. A detailed annotation table of the 
DMRs can be found in the Supplementary Material (Table S7).  
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Discussion 
This study followed a hypothesis-free epigenome-wide (EWAS) approach to identify 
novel differentially methylated sites in the cord blood of neonates exposed to prenatal maternal 
stress. Both the study-specific epigenome-wide analyses in two independent population-based 
cohort studies, Generation R (n = 912) and ALSPAC (n = 828), and the EWAS meta-analysis in 
the total sample (ntotal = 1,740), failed to provide evidence of Bonferroni-corrected DNA 
methylation differences in the cord blood of children exposed to prenatal maternal stress. The 
correlation test of the CpG probes (nCpGs = 39,308) showing an association at a nominal 
threshold level in our EWAS meta-analysis (meta p < .05), indicated convergence between the 
Generation R and ALSPAC samples [r(39,308) = .75, p < .01].   
Even though the current EWAS has significantly more statistical power to detect effects 
than the previous EWAS by Schroeder et al.20, who reported no differential DNA methylation in 
201 neonates born to mothers with a lifetime history of mood disorder, it still finds only weak 
evidence. Cao-Lei et al.21 reported that prenatal exposure to a natural disaster was associated 
with offspring differential methylation (n = 36) in several genes during childhood. Furthermore, 
Non et al.19 showed that DNA methylation differed between neonates exposed to non-medicated 
maternal depression or anxiety (n = 13) versus unexposed neonates (n = 23). It is noteworthy that 
these studies differ in the operationalization (i.e., psychopathology versus natural disaster) and 
the timing (i.e., life-time versus acute) of stress exposure. According to a recent meta-analysis, 
the effect of prenatal maternal stress exposure on infant birth weight and gestational age may 
vary according to how stress is operationalized. 47 In the current study, we used a prenatal 
maternal stress exposure construct that incorporated a variety of stress domains. It is possible 
that the effects of prenatal maternal stress exposure are more subtle than those of acute extremely 
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stressful events (e.g., a natural disaster) and that larger sample sizes are needed to identify these 
small, but potentially biologically important DNA methylation differences in cord blood. 
Another possibility is that there is no genome-wide DNA methylation effect in neonates in the 
general population. Of note, our sensitivity analysis of extreme groups (10% highest versus 10% 
lowest prenatal maternal stress) similarly revealed no Bonferroni-corrected hits, which further 
supports the results of our meta-analysis but was very underpowered to confirm if there is a 
threshold effect of prenatal stress exposure on neonatal DNA methylation. 
Of the CpG probes that did not surpass epigenome-wide thresholds in our study, the top 
hit (cg13529437, meta p = 1.00e-06) was located in chromosome 6p21.1, in the MAD2L1BP 
gene. The product of this gene participates in the mitotic checkpoint complex, acting as a 
regulator of the cell cycle. 48 In cell lines, the MAD2L1BP gene was found to be induced by 
stressful events, such as ionizing radiation. 49 However, in light of the observed sub threshold 
effects, we would like to point out that the exact contribution of this gene in conditions of 
maternal stress exposure is not straightforward and warrants further investigation. 
Exploratory follow-up analysis of the top CpG probes (meta p <1.00e-04) identified by 
our EWAS meta-analysis indicated an over-representation of the methyltransferase activity 
pathway. Methyltransferases are a large group of enzymes with the ability to methylate their 
substrates. 50 Among our top EWAS meta-analytic results, both DNA and protein-
methyltransferases were found. These results support previous research indicating that the 
methyltransferases regulating gene expression through DNA or histone methylation may also be 
under epigenetic control. 51, 52 This fine-tuned regulation of the epigenetic machinery offers an 
attractive system for feedback regulation and/or escalation of the response to initial 
environmental stimuli. For example, it has been suggested that epigenetic gene regulation 
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associated with the altered expression of DNA methyltransferases is responsive to prenatal stress 
exposure53, 54 and involved in the pathophysiology of schizophrenia55, 56 and mood disorders. 57 
Future molecular and animal studies are needed to test this hypothesized mechanism.  
The differentially methylated regions (DMRs) analysis in the Generation R sample 
identified three clusters in 20q13.33, 7q33, and 17q25.1 showing marginal associations with 
prenatal maternal stress. However, we were unable to replicate these clusters in the ALSPAC 
sample. These results highlight a major challenge of epigenetic epidemiology, which is to 
disentangle which associations are sample-specific, stochastic, or replicable, and eventually 
generalizable. 17 
We argue that the stress domains used in the current study, more so than acute disaster-
type stresses studied by Cao-Lei et al.21, are potentially generalizable to the broader population. 
Natural disasters are less common than financial and relationship difficulties, at least in Western 
industrialized countries. These financial and relationship difficulties are potentially more 
amenable to interventions than natural disasters. Hence, understanding the molecular 
consequences could inform prioritization of interventions in public health strategy. Using a more 
normative range of prenatal stresses, the current study promises to have wide-spread 
implications. Because the magnitude of these associations in terms of cell biology are unclear, 
the nominally significant results could include biologically important associations even if the 
change in methylation is quite subtle. Additionally, it is possible that the different stress domains 
exert differential effects on neonatal DNA methylation, and should be tested independently. 
However, in our samples the separate stressors showed skewed distributions that might lead to 
false positive findings. The aggregate score of these stressors better approximated a normal 
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distribution, and therefore was used in our statistical analyses to capture the stressful 
environment to which both the mother and the fetus had been exposed. 
Another potential factor to be taken into account in future EWASs is the timing of the 
prenatal maternal stress exposure. In support of the fetal programming hypothesis, Tobi et al.58 
showed in a recent EWAS that prenatal famine exposure in early gestation, but not in mid or late 
gestation, is associated with DNA methylation. Findings of a recent EWAS by Richmond et al.59 
suggest that, in contrast to the view that early pregnancy represents a critical time-window for 
influencing development, sustained exposure of the fetus to maternal smoking in utero is 
required to induce neonatal DNA methylation modifications. The prenatal maternal stress 
measures used in the current study spanned 12 to 30 weeks of pregnancy and most indicators 
were assessed only once during pregnancy. There is a need for longitudinal EWASs investigating 
the relative roles of the early, mid, and late intrauterine environment in stress-induced DNA 
methylation changes, in order to identify the targets and timing of intervention. 
The present results should be interpreted in the context of three main limitations. First, 
our analyses are limited to cord blood samples with heterogeneous cell types. Although it has 
become common practice to adjust for the proportion of cell types in the blood in EWASs, 35 this 
approach has been validated for adults and not for cord blood samples. Alternative methods are 
needed to assess cell mixture distribution in cord blood. Second, although it has been shown that 
blood samples are adequate proxies of DNA methylation in other tissues (e.g. the brain60), there 
is also accumulative evidence of tissue-specific DNA methylation. 61 Future research could 
investigate the effects of prenatal maternal stress exposure in specific tissues and cell types. 
Finally, an inherent characteristic of EWAS is that methylation at the majority of the CpG probes 
measured by the Illumina 450K array are either fully methylated or unmethylated, showing low 
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variation between individuals. 62 These CpG probes may be irrelevant for gene-expression 
regulation, and it is as yet unclear how this (lack of) variation should be taken into account. The 
Bonferroni correction for multiple testing as applied in this study could be in fact too strict, and 
alternative methods [e.g., selection of intermediate (mean β ≥ 0.3–0.7) or variable (SD ≥ 0.05) 
methylated CpG probes, 62 use of region discovery methods, 44 or estimation of equivalent 
number of independent variables63], are currently under development and can increase the power 
to detect true associations. 
The present population-based study is the first, to our knowledge, to examine the 
association between prenatal maternal stress exposure and offspring genome-wide cord blood 
methylation using meta-analysis and novel region discovery methods. Meta-analysis approaches 
are widely used in genome-wide association studies and have identified many genetic variants 
which could not be revealed in the individual studies. 64 This study may showcase that a straight-
forward approach in EWAS can be unsuccessful in terms of finding significant associations for 
specific probes, and that more sophisticated ways should be employed in epigenetic studies, 
whenever possible. The technical/ methodological properties of methylation arrays (e.g. limited 
coverage of the genome, cross-hybridization65, 66), combined with the fact that inherently small 
effect sizes have been observed in small samples without replication in independent samples or 
model systems (e.g. cell lines and animal models), raise concerns regarding the replicability of 
the findings presented in the literature. 17 
Combining data from two independent population-based samples of mothers and 
neonates in an EWAS meta-analysis, this study identified no single CpG probe with strong 
associations with prenatal maternal stress exposure. The search for differentially methylated 
regions across the genome was followed up with several complementary approaches, including a 
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correlation test, DMRs and pathway analyses. The extent to which the severity, duration and 
timing of prenatal stress exposures associate with neonatal DNA methylation should be further 
investigated in large longitudinal studies with more extreme variations in relevant phenotypes. 
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Table 1. Sample characteristics 
 Generation R (n = 912) ALSPAC (n = 828) 
Child characteristics   
Sex, % girls 48.4 48.9 
Gestational age, weeks 40.2 (1.43) 39.6 (1.50) 
Maternal characteristics   
Age, years 31.7 (4.13) 29.56 (4.39) 
PMSE score, log transformed 0.15 (.11) 0.25 (.14) 
Smoking during pregnancy, %   
never 77.5 87.1 
until pregnancy was confirmed 7.7 3.4 
continued 14.8 9.5 
Values represent mean (standard deviation), unless otherwise specified. 
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Table 2. Summary of the number of CpGs and their proportional distribution according to mean 
methylation (β-value) density in the Generation R and ALSPAC samples 
 Mean β-value in cord blood Total 
 < 0.3 ≥ 0.3 to 0.7 ≥ 0.7  
Generation R      
CpGs (n) 181,765 51,296 202,952 436,013 
CpGs as proportion of total array (%) 42 11 47 100 
ALSPAC      
CpGs (n) 187,967 69,082 220,655 477,704 
CpGs as proportion of total array (%) 39 15 46 100 
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Table 3. Top 10 CpG probes (meta p <1.00e-04) derived from the EWAS meta-analysis of prenatal maternal stress exposure in neonates, 
sorted by ascending meta p-value (ntotal = 1,740) 
   Generation R (n = 912) ALSPAC (n = 828) meta-analysis (ntotal = 1,740)  
Probe name Chromosome Position effect (SE) p effect (SE) p Effect (SE) Direction * Meta P Het P Nearest gene (s) 
cg13529437 6 43607635 -0.04 (.009) 3.31e-06 -0.03 (.016) 1.15e-01 -0.04 (.007) -- 1.00e-06 .47 MAD2L1BP 
cg04129946 2 201753996 0.02 (.006) 2.63e-04 0.02 (.007) 9.71e-03 0.02 (.004) ++ 7.59e-06 .73 PPIL3;NIF3L1 
cg20959676 1 23696021 0.01 (.003) 6.54e-03 0.02 (.005) 1.01e-04 0.01 (.003) ++ 8.67e-06 .09 C1orf213;ZNF436 
cg17631424 4 69312514 -0.06 (.016) 2.64e-04 -0.05 (.022) 1.53e-02 -0.06 (.013) -- 1.13e-05 .81 TMPRSS11E 
cg19459675 4 166249239 0.02 (.005) 7.99e-04 0.02 (.006) 6.72e-03 0.02 (.004) ++ 1.59e-05 .76 SC4MOL 
cg12947485 4 25310668 -0.04 (.010) 6.78e-04 -0.04 (.015) 5.84e-03 -0.04 (.009) -- 1.71e-05 .75 NA 
cg20011562 6 12749352 0.01 (.003) 2.78e-02 0.01 (.004) 9.98e-05 0.01 (.002) ++ 1.85e-05 .18 PHACTR1 
cg02644494 19 6412686 0.02 (.008) 2.30e-03 0.03 (.009) 2.77e-03 0.03 (.006) ++ 1.88e-05 .82 PVRL1 
cg01686933 11 119596104 -0.02 (.008) 6.49e-03 -0.03 (.008) 1.11e-03 -0.02 (.006) -- 2.12e-05 .81 NA 
cg00409356 5 1879525 0.05 (.012) 5.86e-05 0.02 (.013) 5.75e-02 0.04 (.009) ++ 2.17e-05 .17 IRX4 
 
* input order: the Avon Longitudinal Study of Parents and Children (ALSPAC) Study, the Generation R Study 
The prenatal maternal stress exposure score was not standardized and findings cannot be directly compared across ALSPAC and the Generation R Study. 
NA- not available 
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Figure 1. Manhattan plot of the EWAS meta-analysis of the PMSE score in cord blood (ntotal = 
1,740). The x-axis represents the autosomal (1-22) and sex (X,Y) chromosomes and the y-axis 
shows the –log10(p). The red line indicates the Bonferroni-corrected epigenome-wide threshold (p 
= 1.00e-07) 
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Figure 2. Quantile-quantile (QQ) plot illustrating probability values from the EWAS meta-
analysis of the PMSE score in cord blood (ntotal = 1,740). The red line indicates the distribution 
under the null hypothesis and the shaded area indicates the 95% confidence band. 
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Table 4. Pathway analysis of top CpG probes (meta p < 1.00e-04) derived from the EWAS meta-analysis of prenatal maternal stress 
exposure in neonates (ntotal = 1,740) 
Pathway tool Output 
PANTHER GO-slim Molecular Function Expected ngenes Observed ngenes Fold enrichment Pathway enrichment p 
methyltransferase activity 0.26 4 > 5 .002 $ 
DAVID Count Coverage Enrichment score Pathway enrichment p 
methyltransferase activity 5 1.1% 2.46 .06 * 
GeneMANIA   Coverage Pathway enrichment p 
methyltransferase activity   7/87 4.76e-04* 
 
$ PANTHER reports the Bonferroni method 
* DAVID and GeneMANIA report the Benjamini-Hochberg (false-discovery rate, FDR) method 
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Table 5. Top Differential Methylated Regions (DMRs) associated with prenatal maternal stress exposure in the Generation R (n =912) 
and ALSPAC (n = 828) samples  
Cluster Number  n CpGs 
 
Chromosome Start Position End Position pGeneration R pALSPAC Nearest gene(s) 
90946 3 20 62948037 62948235 3.75e-06 0.72 MYT1;LINC00266-1;CICP4 
135488 11 7 133811808 133812369 1.27e-05 0.52 LRGUK 
66361 15 17 73974861 73976089 3.55e-04 0.63 ACOX1; C17orf106 
 
